Category: Compliance

FieldWatch, the world’s premier solution for direct sales compliance, now offers a unique approach for group monitoring and enforcement in its latest release.

All of us at Momentum Factor are excited to announce the 20th major customer for FieldWatch and that more platform enhancements are scheduled to release soon.

Momentum Factor Founder & CEO Jonathan Gilliam to speak at the Direct Selling Academy's Vemma Injunction Event being held at the Zermatt Conference Center in Midway, Utah, on Tuesday, January 12.

Momentum Factor's FieldWatch™ platform was recently featured in yet another Forrester Report: TechRadar™: Risk Management, 2015.

Every time a direct seller has an issue with the Federal Trade Commission (FTC), critics of the industry are quick to jump on it, hailing it as a step in the right direction towards shutting down multi-level marketing completely. They’ll say that it is finally being outed as an unsustainable business practice — that they’re all just pyramid schemes in disguise.

In the wake of recent FTC actions, a new pattern of consumer protection action has emerged: companies who go too far in their marketing or give the appearance of an anti-consumer bias may be putting their companies at great risk.

Judge John J. Tuchi yesterday amended his temporary restraining order in the Vemma case – and it has HUGE ramifications for direct sellers. Join us on Tuesday, September 22 at 1 pm Central for a critical update webcast to discuss these important industry developments.

Great article from the Harvard Business Review on how risk should be integrated in a company's day-to-day operation rather than as a side function.

We are proud to announce that the Momentum Factor team and CEO Jonathan Gilliam will be in attendance at this year's DSA Canada Annual Meeting from June 24-25 in Niagra Falls, Ontario. Gilliam will deliver the latest cutting-edge content to the world's greatest direct selling executives at this year's "We Have the Power!" annual meeting as he will be speaking during an 11:00 am Tuesday morning session.

The FDA says it wants input on whether it needs to do more to ensure that remedies are safe and effective. This article from The Washington Post examines the desire of the FDA to revisit its oversight on homeopathic products.